Picture of Craven House Capital logo

CRV — Craven House Capital News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Brief: Craven House Capital Says Bio Vitos Has Entered Into Deal With Hemcheck

Feb 8 (Reuters) - Craven House Capital PLC  CRV.L :
    * INVESTEE COMPANY UPDATE: BIO VITOS
    * 24.5% OWNED INVESTEE COMPANY BIO VITOS HAS ENTERED INTO AN
AGREEMENT WITH HEMCHECK TO CREATE A NEW SUBSIDIARY

Source text for Eikon:  ID:nRSH2316Pa 
Further company coverage:  CRV.L 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Craven House Capital

See all news